Login / Signup

Molecular landmarks of tumor hypoxia across cancer types.

Vinayak BhandariChristianne HoeyLydia Y LiuEmilie LalondeJessica RayJulie LivingstoneRobert LesurfYu-Jia ShiahTina VujcicXiaoyong HuangShadrielle M G EspirituLawrence E HeislerFouad YousifVincent HuangTakafumi N YamaguchiCindy Q YaoVeronica Y SabelnykovaMichael FraserMelvin L K ChuaTheodorus van der KwastStanley K LiuPaul C BoutrosRobert G Bristow
Published in: Nature genetics (2019)
Many primary-tumor subregions have low levels of molecular oxygen, termed hypoxia. Hypoxic tumors are at elevated risk for local failure and distant metastasis, but the molecular hallmarks of tumor hypoxia remain poorly defined. To fill this gap, we quantified hypoxia in 8,006 tumors across 19 tumor types. In ten tumor types, hypoxia was associated with elevated genomic instability. In all 19 tumor types, hypoxic tumors exhibited characteristic driver-mutation signatures. We observed widespread hypoxia-associated dysregulation of microRNAs (miRNAs) across cancers and functionally validated miR-133a-3p as a hypoxia-modulated miRNA. In localized prostate cancer, hypoxia was associated with elevated rates of chromothripsis, allelic loss of PTEN and shorter telomeres. These associations are particularly enriched in polyclonal tumors, representing a constellation of features resembling tumor nimbosus, an aggressive cellular phenotype. Overall, this work establishes that tumor hypoxia may drive aggressive molecular features across cancers and shape the clinical trajectory of individual tumors.
Keyphrases
  • prostate cancer
  • endothelial cells
  • cell proliferation
  • lymph node
  • gene expression
  • signaling pathway
  • dna methylation
  • pi k akt
  • childhood cancer